Regen BioPharma Inc (RGBP) shareholders
RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026Market cap $92.33KP/E –Yield –
Ownership
Who owns Regen BioPharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Quick Capital, LLC | 10 | 9.90% | 13G (passive) | Sep 10, 2025 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 6M shares a day
Change since last report
-37.9%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Regen BioPharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,531,995 shares on Oct 1, 2026 over the last 90 days.
See a number that looks wrong?